Improved Functioning in a Woman with Schizophrenia on Exclusive Therapy with Oestrogen Pills

2002 ◽  
Vol 10 (4) ◽  
pp. 403-404 ◽  
Author(s):  
Mosunmola Tunde-Ayinmode ◽  
Ashok Singh ◽  
Karen Marsden

Objective: To highlight the therapeutic potential of oestrogen in schizophrenia and raise awareness about the need for more clinical trials. Method: Case Report. Results: The case concerns a woman suffering from chronic paranoid schizophrenia, who complied poorly with antipsychotic medication and had severely impaired psychological and social functioning. Oestrogen therapy in the form of an oral contraceptive pill (brevinor- norethisterone/ ethinyloestradiol) was used with effect. Conclusions: Oestrogen therapy shows promise in select cases in the treatment of schizophrenia and warrants further study.

Gut ◽  
2013 ◽  
Vol 62 (Suppl 2) ◽  
pp. A37.1-A37
Author(s):  
C Kiat ◽  
Y Y Hong ◽  
C Connolly ◽  
V Byrnes

Author(s):  
Safa moussaoui ◽  
mehdi abdelwahed ◽  
Nabil Ben Chaabene ◽  
Ahlem Bellalah ◽  
Najeh Ben Fadhel ◽  
...  

Case presentation: This case report concerns a 49-year-old woman who developed norethisterone drug -induced cholestasis, a progestin contraceptive, which is quite rare complication generally observed with estrogenic component of combined oral contraceptive pill.


2001 ◽  
Vol 46 (5) ◽  
pp. 147-147
Author(s):  
T. Quasim ◽  
P. Horgan

As the use of the oral contraceptive pill increases, so does the incidence of hepatic adenomata. This condition can present as an acute surgical emergency in the previously healthy female but is often overlooked as a possible diagnosis. This report illustrates such a case and its sometimes unusual presentation.


Sign in / Sign up

Export Citation Format

Share Document